ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,681Medicare Part D Prescriptions Filled, Including Refills

Rank: 116 out of 973

$615K Total Retail Price of All Prescriptions

Rank: 68 out of 973

462 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,487 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
AMLODIPINE BESYLATE 492 397 1 7
LEVOTHYROXINE SODIUM 451 343 2 2
SIMVASTATIN 420 268 3 1
LISINOPRIL 413 297 4 3
OMEPRAZOLE 340 248 5 5
ATORVASTATIN CALCIUM 329 245 6 15
PRAVASTATIN SODIUM 281 234 7 22
MELOXICAM 243 173 8 23
METFORMIN HCL 241 172 9 8
HYDROCHLOROTHIAZIDE 204 148 10 11
HYDROCODONE-ACETAMINOPHEN 198 163 S3 11 4
CRESTOR 186 150 12 34
ALENDRONATE SODIUM 183 174 13 24
WARFARIN SODIUM 169 117 14 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 112 15 25
TRAMADOL HCL 154 101 16 18
LOSARTAN POTASSIUM 146 123 17 19
FUROSEMIDE 142 125 18 6
TRICOR 134 64 19 143
METOPROLOL TARTRATE 128 98 20 13
GABAPENTIN 118 60 21 12
ALLOPURINOL 106 82 22 29
METOPROLOL SUCCINATE 101 90 23 17
ATENOLOL 97 60 24 16
JANUVIA 91 66 25 88
LIPITOR 90 71 26 139
CARVEDILOL 89 44 27 27
AMLODIPINE BESYLATE-BENAZEPRIL 89 39 27 80
NEXIUM 89 45 27 30
LOSARTAN-HYDROCHLOROTHIAZIDE 83 73 30 46
CITALOPRAM HBR 81 72 31 14
ZETIA 75 50 32 81
BENAZEPRIL HCL 75 62 32 62
ADVAIR DISKUS 74 31 34 60
CYMBALTA 70 50 35 40
GLYBURIDE 67 37 R 36 59
GLYBURIDE MICRONIZED 65 65 R 37 232
SERTRALINE HCL 65 46 37 21
METFORMIN HCL ER 64 29 39 58
FLUTICASONE PROPIONATE 64 41 39 35
TRIAMTERENE-HCTZ 63 52 41 51
GLYBURIDE-METFORMIN HCL 63 26 R 41 193
AMITRIPTYLINE HCL 63 19 R 41 52
POTASSIUM CHLORIDE 60 21 44 9
TAMSULOSIN HCL 60 49 44 28
SYNTHROID 60 56 44 50
GLIMEPIRIDE 57 57 47 41
EVISTA 55 53 48 121
BENICAR 53 33 49 231
ACTOS 52 32 50 119
BENICAR HCT 50 50 51 308
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.